118 related articles for article (PubMed ID: 11194951)
1. [Concomitant radiochemotherapy in cancer of the cervix uteri: modifications of the standards].
Haie-Meder C; Lhommé C; de Crevoisier R; Morice P; Resbeut M
Cancer Radiother; 2000 Nov; 4 Suppl 1():134s-140s. PubMed ID: 11194951
[TBL] [Abstract][Full Text] [Related]
2. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Dunst J; Haensgen G
Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
[TBL] [Abstract][Full Text] [Related]
4. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
5. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
6. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
[TBL] [Abstract][Full Text] [Related]
7. Organ preservation in locally advanced carcinoma of the uterine cervix.
Smaniotto D; Andrulli AD; Tortoreto F; Niespolo RM; Valentini V
Rays; 1997; 22(3):472-7. PubMed ID: 9446953
[TBL] [Abstract][Full Text] [Related]
8. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
10. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study.
Vrdoljak E; Prskalo T; Omrcen T; Situm K; Boraska T; Frleta Ilić N; Janković S; Hamm W
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):824-9. PubMed ID: 15708262
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of concurrent radiotherapy and chemotherapy for locally advanced cervical cancer: 12-Year survival after radiochemotherapy.
Berclaz G; Gerber E; Beer K; Aebi S; Greiner R; Dreher E; Buser K
Int J Oncol; 2002 Jun; 20(6):1313-8. PubMed ID: 12012015
[TBL] [Abstract][Full Text] [Related]
13. [Retrospective study of chemoradiotherapy based on cisplatin compared with radiotherapy alone for cervical cancer].
Han C; Kong WM
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):723-6. PubMed ID: 18307894
[TBL] [Abstract][Full Text] [Related]
14. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
[TBL] [Abstract][Full Text] [Related]
15. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: a phase I-II study.
Viegas CM; Araujo CM; Dantas MA; Froimtchuk M; Oliveira JA; Marchiori E; Souhami L
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1154-9. PubMed ID: 15519787
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
Eifel PJ
Nat Clin Pract Oncol; 2006 May; 3(5):248-55. PubMed ID: 16683003
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]